Refine
Has Fulltext
- yes (43)
Is part of the Bibliography
- yes (43)
Year of publication
Document Type
- Journal article (30)
- Doctoral Thesis (13)
Keywords
- multiple sclerosis (43) (remove)
Institute
- Neurologische Klinik und Poliklinik (22)
- Institut für Anatomie und Zellbiologie (11)
- Institut für Virologie und Immunbiologie (4)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (2)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (2)
- Frauenklinik und Poliklinik (1)
- Graduate School of Life Sciences (1)
- Institut für Informatik (1)
- Institut für Psychologie (1)
- Institut für Psychotherapie und Medizinische Psychologie (1)
EU-Project number / Contract (GA) number
- 026155 (1)
While there is abounding literature on virus-induced pathology in general and coronavirus in particular, recent evidence accumulates showing distinct and deleterious brain affection. As the respiratory tract connects to the brain without protection of the blood–brain barrier, SARS-CoV-2 might in the early invasive phase attack the cardiorespiratory centres located in the medulla/pons areas, giving rise to disturbances of respiration and cardiac problems. Furthermore, brainstem regions are at risk to lose their functional integrity. Therefore, long-term neurological as well as psychiatric symptomatology and eventual respective disorders cannot be excluded as evidenced from influenza-A triggered post-encephalitic Parkinsonism and HIV-1 triggered AIDS–dementia complex. From the available evidences for coronavirus-induced brain pathology, this review concludes a number of unmet needs for further research strategies like human postmortem brain analyses. SARS-CoV-2 mirroring experimental animal brain studies, characterization of time-dependent and region-dependent spreading behaviours of coronaviruses, enlightening of pathological mechanisms after coronavirus infection using long-term animal models and clinical observations of patients having had COVID-19 infection are calling to develop both protective strategies and drug discoveries to avoid early and late coronavirus-induced functional brain disturbances, symptoms and eventually disorders. To fight SARS-CoV-2, it is an urgent need to enforce clinical, molecular biological, neurochemical and genetic research including brain-related studies on a worldwide harmonized basis.